This episode talks about the procedures of vaccine invention and manufacturing and about the new technology of mRNA
Prof Kiat Ruxrungtham from the Center of Excellence in Vaccine Research Center and Development. Photo courtesy of Chulalongkorn Hospital
Kiat Ruxrungtham isn’t content to see Thailand wait in line to buy vaccines from another country.
The first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health
Thailand is tightening border controls as the country faces its worst coronavirus outbreak.
Chulalongkorn University’s mRNA Covid-19 vaccine, ChulaCov19, began its first round of human trials
ChulaCov19 designer Kiat Ruxrungtham talks about his aim to make Thailand an mRNA vaccine hub
A race to develop a vaccine against Covid-19 is paving the way for researchers in Thailand to produce inoculations against other diseases.
To attend the Global Vaccine and Immunization Research Forum (GVIRF) 2018.
